Risk assessment for chemical carcinogens

Molecular Carcinogenesis and the Molecular Biology of Human Cancer

Volumn , Issue , 2005, Pages 501-546

  Salmon, Andrew G ^a  

^a CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38849197854     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (57)

1. Abbott, W.S. (1925). A method of computing the effectiveness of an insecticide. J. EconEntomol., 18: 265-267.
2. Anderson, E.L. and the U.S. Environmental Protection Agency Carcinogen Assessment Group (1983) Quantitative approaches in use to assess cancer risk. Risk Anal., 3, 277-295.
3. Armitage, P. and Doll, R. (1954) The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer, 8, 1-12.
4. Bailar, J.C. and Bailer, A.J. (1999) Risk assessment— the mother of all uncertainties. Disciplinary perspectives on uncertainty in risk assessment. Ann. N.Y. Acad. Sci., 895, 273-285.
5. Barrett, J.C. and Wiseman, R.W. (1987) Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. Environ. Health. Perspect., 78, 65-70.
6. Benya, T.J., Busey, W.M., Dorato, M.A., and Berteau, P.E. (1982) Inhalation carcinogenicity bioassay of vinyl bromide in rats. Toxicol. Appl. Pharmacol., 64, 367-379.
7. Chemical Industry Institute of Toxicology (CIIT, 1999) Formaldehyde: Hazard Characterization and Dose-Response Assessment for Carcinogenicity by the Route of Inhalation, revised ed. Chemical Industries Institute of Toxicology, September 28, 1999, Research Triangle Park, NC. (Unfortunately, the part of these studies relating to the cell proliferation model has not yet been published in the open literature, but this report is currently available on request from CIIT.)
8. Cogliano, V.J., Hiatt, G.F.S., and Den, A. (1996) Quantitative cancer assessment for vinyl chloride: Indications of early-life sensitivity. Toxicology, 111, 21-28.
9. Collins, J.F., Brown, J.P., Alexeeff, G.V., and Salmon, A.G. (1998) Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Pharmacol., 28, 45-54.
10. Creech, J.L., Jr., and Johnson, M.N. (1974) Angiosarcoma of liver in the manufacture of polyvinyl chloride. J. Occup. Med., 16, 150-151.
11. Crouch, E. (1983). Uncertainties in interspecies extrapolations of carcinogenicity. Environ. Health Perspect, 5: 321-327.
12. Crump, K.S. (1981) An improved procedure for low-dose carcinogenic risk assessment from animal data. J. Environ. Pathol. Toxicol., 52, 675-684.
13. Crump, K.S. and Howe, R.B. (1984) The multistage model with a time-dependent dose pattern: Applications to carcinogenic risk assessment. Risk. Anal., 4, 163-176.
14. Crump, K.S., Guess, H.A., and Deal, L.L. (1977) Confidence intervals and test of hypotheses concerning dose-response relations inferred from animal carcinogenicity data. Biometrics, 33, 437-451.
15. Dawson, S.V. and Alexeeff, G.V. (2001) Multi-stage model estimates of lung cancer risk from exposure to diesel exhaust, based on a U.S. railroad worker cohort. Risk Anal., 21, 1-18.
16. Garshick, E., Schenker, M., Munoz, A., Segal, M., Smith, T., Woskie, S., Hammond, S., and Speizer, F. (1988) A retrospective cohort study of lung cancer and diesel exhaust exposure in railroad workers. Am. Rev. Respir. Dis., 137, 820-825.
17. Ginsberg, G., Smolenski, S., Hattis, D., and Sonawane, B. (2002) Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: Implications for risk assessment. Regul. Toxicol. Pharmacol., 36, 297-309.
18. Gold, L.S., Sawyer, C.B., Magaw, R., Backman, G., deVeciana, M., Levinson, R., Hooper, N.K., Havender, W.R., Bernstein, L., Peto, R., Pike, M., Ames, B.N. (1984). A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect., 58: 9-319.
19. Hill, A.B. (1965) The environment and disease: Association or causation? Proc. Roy. Soc. Med., 58, 295-300.
20. Hill, A.B. (1971) Statistical evidence and inference. In Principles of Medical Statistics., (A.B. Hill, Ed.) Oxford University Press, Oxford, UK/New York, pp. 309-323.
21. Hill, R. (1925) Proc. R. Soc., B100, 419. For amore accessible description of the Hill equation and its modern interpretations and implications, see any standard biochemistry textbook.
22. International Agency for Research on Cancer (IARC, ongoing series) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC, Lyon. See also http://monographs.iarc.fr/.
23. Krewski, D., Crump, K.S., Farmer, J., Gaylor, G.W., Howe, R., Portier, C., Salsburg, D., Sielkin, R.L., van Ryzin, J. (1983). A comparison of statistical methods for low dose extrapolation utilizing tie-to-tumor data. Fund Appl Toxicol 3: 140-160.
24. Leung, H.-W. (1999) Chapter 7: Physiologically based pharmacokinetic modeling. In General and Applied Toxicology, Ballantyne, B., Marrs, T.C., Syversen, T., Eds. McMillan, London, UK, 1999 and Groves’ Dictionaries, New York, 1999, chapter 7.
25. Lilienfeld, A.M. and Lilienfeld, D.E. (1980) Foundations of Epidemiology. Oxford University Press, Oxford, UK and New York, 375 pp.
26. Mancuso, T. (1975) Consideration of chromium as an industrial carcinogen. In Proceedings of the International Conference on Heavy Metals in the Environment. Toronto, Ontario, Canada, pp. 343-356.
27. Mancuso, T. and Hueper, W. (1951) Occupational cancer and other health hazards in a chromate plant: A medical appraisal. I. Lung cancers in chromate workers. Indust. Med. Surg., 20, 358-363.
28. Medinsky, M.A. and Valentine, J.L. (2001) Toxicokinetics. In Casarett and Doull’s Toxicology, 6th ed. Klaassen, C.D., Ed. McGraw-Hill, New York, 2001, Chapter 7.
29. Meigs, J.W., Marrett, L.D., Ulrich, F.U., and Flannery, J.T. (1986) Bladder tumor incidence among workers exposed to benzidine: A thirty-year follow-up. J. Natl. Cancer Inst., 76, 1-8.
30. Moolgavkar, S.H. and Knudson, A.G. (1981) Mutation and cancer: A model for human carcinogenesis. J. Natl. Cancer Inst., 66, 1037-1052.
31. National Research Council (NRC, 1983) Risk Assessment in the Federal Government: Managing the Process. (Committee on the Institutional Means for Assessment of Risks to Public Health, Commission on Life Sciences, National Research Council) National Academies Press, Washington, DC, 191 pp.
32. National Research Council (NRC, 1994) Science and Judgment in Risk Assessment. (Committee on Risk Assessment of Hazardous Air Pollutants, National Research Council) National Academies Press, Washington, DC, 1983, 672 pp.
33. National Research Council (NRC, 1996) Understanding Risk: Informing Decisions in a Democratic Society. (Stern, P.C. and Fineberg, H.V., Eds., Committee on Risk Characterization, National Research Council.) National Academies Press, Washington, DC, 264 pp.
34. National Toxicology Program (NTP, 1986) Toxicology and Carcinogenesis Studies of Tetrachloroethylene (Perchloroethylene) in F344/N Rats and B6C3Fj Mice (Inhalation Studies). TR 311, NIH publication no. 86-2567. National Toxicology Program, Research Triangle Park, NC.
35. National Toxicology Program (NTP, 1998) Toxicology and Carcinogenesis Studies on Chloroprene in F344/N Rats and B6C3Fi Mice. TR 467, NIH publication no. 98-3957. National Toxicology Program, Research Triangle Park, NC.
36. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency (OEHHA, 1999a) Public Health Goal for Methyl Tertiary Butyl Ether (MTBE) in Drinking Water. Available from http://oehha.ca.gov/water/phg/pdf/mtbe_f.pdf.
37. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency (OEHHA, 1999b) Air Toxics Hot Spots Program: Risk Assessment Guidelines, Part II. Technical Support Document for Describing Available Cancer Potency Factors. Available from the OEHHA Web site: http://www.oehha.ca.gov/air/cancer_guide/hsca2.html#download.
38. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency (2000) Air Toxics Hot Spots Program: Risk Assessment Guidelines, Part IV. Exposure Assessment and Stochastic Analysis Technical Support Document.
39. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency (OEHHA, 2001) Prioritization of Toxic Air Contaminants — Children’s Environmental Health Protection Act — Final Report. Available from the OEHHA website: http://www.oehha.ca.gov/air/toxic_contaminants/SB25finalreport.htm.
40. Poiley, S.M. (1972) Growth tables for 66 strains and stocks of laboratory animals. Lab. Animal Sci., 22, 759-779.
41. Portier, C.J., Kopp-Schneider, A., and Sherman, C.D. (1993) Using cell replication data in mathematical modeling in carcinogenesis. Environ. Health Perspect., 101 (Suppl. 5), 79-86. (This volume presents the proceedings of a conference on cell proliferation and carcinogenesis, and contains a number of review articles relevant to this topic.)
42. Pott, P. (1775) Chirurgical Observations Relative to the Cataract, the Polypus of the Nose, the Cancer of the Scrotum, the Different Kinds of Ruptures, and the Mortifications of the Toes and Feet. London, UK, Hawse, Clark and Collins.
43. Redmond, C.K. (1983) Cancer mortality among coke oven workers. Environ. Health Perspect., 52, 67-73.
44. Rothman, R (1986) Modern Epidemiology. Little, Brown & Co., Boston, M.A. and Toronto, Canada, 358 pp.
45. Salmon, A.G., Monserrat, L., and Brown, J.P. (1992) Use of a pharmacokinetic model in cancer risk assessment for vinyl bromide. Presented at the Society of Toxicology Annual Meeting, Seattle, WA, February 1992. Abstract: Toxicologist, 12, 96.
46. US EPA (1986) Guidelines for Carcinogen Risk Assessment. EPA/630/R-00/004. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC, September 1986. Published: Federal Register 51, 33992-34003, September 24, 1986.
47. See the US EPA’s website: http://www.epa.gov/ncea/raf/car2sab/guidelines_1986.pdf.
48. US EPA (1994) U.S. Environmental Protection Agency Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90/066F. Office of Research and Development. Washington, DC.
49. US EPA (1995) Use of the Benchmark Dose Approach in Health Risk Assessment. EPA/630/R-94/007. 01 Feb. 1995. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC, 100 pp.
50. US EPA (1988). Recommendations for and documentation of biological values for use in risk assessment. EPA/600/6-87-008. Office of Health and Environmental Assessment, Cincinnati, OH, 1988.
51. US EPA (1999) IEUBK Model Bioavailability Variable. EPA #540-F-00-006 OSWER #9285.7-32 October 1999. Office of Solid Waste and Emergency Response, U.S. Environmental Protection Agency, Washington, DC. See http://www.epa.gov/superfund/programs/lead/products/sspbbioc.pdf.
52. US EPA (2000a) Toxicological Review of Vinyl Chloride in Support of Summary Information on the Integrated Risk Information System (IRIS). U.S. Environmental Protection Agency, Washington, DC, May 2000.
53. US EPA (2000b). Draft Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds. U.S. Environmental Protection Agency, Washington, DC, September 2000. On the US EPA’s website: http://cfpub.epa.gov/ncea/cfm/dioxreass.cfm.
54. US EPA (2003a) Draft Final Guidelines for Carcinogen Risk Assessment (External review draft, February 2003). NCEA-F-0644A. 03 March 2003. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC, 125 pp. (1999). See the US EPA’s website (NCEA/Risk assessment forum): http://cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid=55868 for this document, prior versions and supporting materials. Note: On March 29, 2005 the US EPA released a final version of their Guidelines for Carcinogen Risk Assessment, which is available at http://cfpub.epa.gov/ncea/cfm/recorddisplay.cfm?deid=11628. The basic elements of the guidelines are not different from those in the most recent draft version published in 2003, although there are some updates and revisions at the detail level.
55. US EPA (2003b) Integrated Risk Information System (IRIS). On the US EPA’s website: http://www.epa.gov/iris/.
56. van den Berg, M., Birnbaum, L., Bosveld, A.T.C., Brunstrom, B., Cook, P., Feeley, M., Giesy, J.P., Hanberg, A., Hasegawa, R., Kennedy, S.W., Kubiak, T., Larsen, J.C., Van Leeuwen, F.X.R., Liem, A.K.D., Nolt, C., Peterson, R.E., Poellinger, L., Safe, S., Schrenk, D., Tillitt, D., Tysklind, M., Younes, M., Waern, F., and Zacharewski, T. (1998) Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect., 106, 775-792.
57. van Leeuwen, F.X.R. (1997) Derivation of toxic equivalency factors (TEFs) for dioxin-like compounds in humans and wildlife. Organohalogen Compounds, 34, 237.